Advertisement
Advertisement

NUVB

NUVB logo

Nuvation Bio Inc.

6.81
USD
Sponsored
+0.04
+0.59%
Sep 04, 15:59 UTC -4
Closed
exchange

After-Market

6.88

+0.07
+1.03%

NUVB Earnings Reports

Positive Surprise Ratio

NUVB beat 15 of 22 last estimates.

68%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$37.36M
/
-$0.12
Implied change from Q2 26 (Revenue/ EPS)
+17.91%
/
-20.00%
Implied change from Q3 25 (Revenue/ EPS)
+184.77%
/
-25.00%

Nuvation Bio Inc. earnings per share and revenue

On Aug 06, 2026, NUVB reported earnings of -0.15 USD per share (EPS) for Q2 26, beating the estimate of -0.18 USD, resulting in a 20.55% surprise. Revenue reached 31.69 million, compared to an expected 28.06 million, with a 12.94% difference. The market reacted with a -4.08% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analysts forecast an EPS of -0.12 USD, with revenue projected to reach 37.36 million USD, implying an decrease of -20.00% EPS, and increase of 17.91% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-
Surprise
-
logo
Anavex Life Sciences
Report Date
Aug 25, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
logo
Molecular Partners AG - ADR
Report Date
Aug 25, 2026 For Q2 26
Estimate
-
Actual
-$0.35
Surprise
-
FAQ
For Q2 2026, Nuvation Bio Inc. reported EPS of -$0.15, beating estimates by 20.55%, and revenue of $31.69M, 12.94% above expectations.
The stock price moved down -4.08%, changed from $6.37 before the earnings release to $6.11 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 8 analysts, Nuvation Bio Inc. is expected to report EPS of -$0.12 and revenue of $37.36M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement